| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |